|
1
|
Lameier NH, Flombaum CD, Moreau D and
Ronco C: Acute renal failure in cancer patients. Ann Med. 37:13–25.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Finkel KW and Foringer JR: Renal disease
in patients with cancer. Nat Clin Pract Nephrol. 3:669–678. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Humphreys BD, Soiffer RJ and Magee CC:
Renal failure associated with cancer and its treatment: An update.
J Am Soc Nephrol. 16:151–161. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Perazella MA and Moeckel GW:
Nephrotoxicity from chemotherapeutic agents: Clinical
manifestations, pathobiology, and prevention/therapy. Semin
Nephrol. 30:570–581. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang T, Ma HC, Bai YL, Zhang JX and Xu JS:
Continuous venovenous hemodiafiltration, impedance cardiography and
critical care nephrology: A case study of chronic myeloid
leukemia-associated acute renal failure. Crit Care Shock. 14:19–23.
2011.
|
|
6
|
Yerram P, Karuparthi PR and Misra M: Fluid
overload and acute kidney injury. Hemodial Int. 14:348–354. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Soares M, Salluh JI, Carvalho MS, Darmon
M, Ronco JR and Spector N: Prognosis of critically ill patients
with cancer and acute renal dysfunction. J Clin Oncol.
24:4003–4010. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Benoit DD, Hoste EA, Depuydt PO, Offner
FC, Lameire NH, Vandewoude KH, Dhondt AW, Noens LA and Decruyenaere
JM: Outcome in critically ill medical patients treated with renal
replacement therapy for acute renal failure: Comparison between
patients with and those without haematological malignancies.
Nephrol Dial Transplant. 20:552–558. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Darmon M, Thiery G, Ciroldi M, Porcher R,
Schlemmer B and Azoulay E: Should dialysis be offered to cancer
patients with acute kidney injury? Intensive Care Med. 33:765–772.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berghmans T, Meert AP, Markiewicz E and
Sculier JP: Continuous venovenous haemofiltration in cancer
patients with renal failure: A single-centre experience. Support
Care Cancer. 12:306–311. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kazory A and Ross EA: Contemporary trends
in the pharmacological and extracorporeal management of heart
failure: A nephrologic perspective. Circulation. 117:975–983. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Packer M, Abraham WT, Mehra MR, Yancy CW,
Lawless CE, Mitchell JE, Smart FW, Bijou R, O'Connor CM, Massie BM,
et al: Utility of impedance cardiography for the identification of
short-term risk of clinical decompensation in stable patients with
chronic heart failure. J Am Coll Cardiol. 47:2245–2252. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salahudeen AK and Bonventre JV:
Onconephrology: The latest frontier in the war against kidney
disease. J Am Soc Nephrol. 24:26–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kidney Disease: Improving Global Outcomes
(KDIGO) Acute Kidney Injury Work Group: KDIGO clinical practice
guideline for acute kidney injury. Kidney Int Suppl. 2:19–36.
2012.
|
|
15
|
Wang T, Zhang Y, Ma J, Feng Z, Niu K and
Liu B: Additive effect of polymorphisms in the β2-adrenoceptor and
NADPH oxidase p22 phox genes contributes to the loss of estimated
glomerular filtration rate in Chinese. Clin Exp Pharmacol Physiol.
41:657–662. 2014.PubMed/NCBI
|
|
16
|
Dimopoulos M, Kyle R, Fermand JP, Rajkumar
SV, San Miguel J, Chanan-Khan A, Ludwig H, Joshua D, Mehta J, Gertz
M, et al: Consensus recommendations for standard investigative
workup: Report of the international myeloma workshop consensus
panel 3. Blood. 117:4701–4705. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Donauer J, Kölblin D, Bek M, Krause A and
Böhler J: Ultrafiltration profiling and measurement of relative
blood volume as strategies to reduce hemodialysis-related side
effects. Am J Kidney Dis. 36:115–123. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Christiansen CF, Johansen MB, Langeberg
WJ, Fryzek JP and Sørensen HT: Incidence of acute kidney injury in
cancer patients: A Danish population-based cohort study. Eur J
Intern Med. 22:399–406. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mehta RL, McDonald B, Gabbai F, Pahl M,
Farkas A, Pascual MT, Zhuang S, Kaplan RM and Chertow GM:
Nephrology consultation in acute renal failure: Does timing matter?
Am J Med. 113:456–461. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thajudeen B and Salahudeen AK: Role of
tolvaptan in the management of hyponatremia in patients with lung
and other cancers: Current data and future perspectives. Cancer
Manag Res. 8:105–114. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jaeger JQ and Mehta RL: Assessment of dry
weight in hemodialysis: An overview. J Am Soc Nephrol. 10:392–403.
1999.PubMed/NCBI
|
|
22
|
Seo-Mayer P, Kenney B, McNamara J, Stein J
and Moeckel GW: Hematuria and decreased kidney function as initial
signs of acute B-cell lymphoblastic leukemia. Am J Kidney Dis.
56:1001–1005. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Segal A: A case of acute kidney injury due
to complex, partial, multifocal ureteral strictures. Nat Clin Pract
Nephrol. 4:102–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pabla N and Dong Z: Cisplatin
nephrotoxicity: Mechanisms and renoprotective strategies. Kidney
Int. 73:994–1007. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Perazella MA: Renal vulnerability to drug
toxicity. Clin J Am Soc Nephrol. 4:1275–1283. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miller RP, Tadagavadi RK, Ramesh G and
Reeves WB: Mechanisms of cisplatin nephrotoxicity. Toxins (Basel).
2:2490–2518. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
de Jonge MJ and Verweij J: Renal
toxicities of chemotherapy. Semin Oncol. 33:68–73. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Badid C, McGregor B, Faivre JM, Guerard A,
Juillard L, Fouque D and Laville M: Renal thrombotic
microangiography induced by interfon-alpha. Nephrol Dial
Transplant. 16:846–848. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kyle RA, Remstein ED, Therneau TM,
Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, Plevak MF,
Jelinek DF, Fonseca R, et al: Clinical course and prognosis of
smoldering (asymptomatic) multiple myeloma. N Engl J Med.
356:2582–2590. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Jancelewicz Z, Takatsuki K, Sugai S and
Pruzanski W: IgD multiple myeloma: review of 133 cases. Arch Intern
Med. 135:87–93. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shimamoto Y, Anami Y and Yamaguchi M: A
new risk grouping for IgD myeloma based on analysis of 165 Japanese
patients. Eur J Haematol. 47:262–267. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sinclair D and Cranfield T: IgD myeloma: A
potential missed diagnosis. Ann Clin Biochem. 38:564–565. 2001.
View Article : Google Scholar : PubMed/NCBI
|
